Blog in Finnish Chemical Magazine Kemia-Kemi on 24 January 2022:
Great things are currently happening in the Finnish health and life sciences sector. But how can we boost innovation and make health an even better growth engine for Finland? By improving enabling legislation, increasing public RDI funding and attracting international investors, says Juha Paakkola, Director of Health Capital Helsinki. The blog was first published in Finnish Chemical Media on 24 January 2022.
Juha Paakkola, Director, Health Capital HelsinkiNew campus incubators in Helsinki, new quantum computer, Lumi Supercomputer, new startups, listings, acquisitions and investments. Rokote Laboratories is developing a vaccine for COVID-19 with more than €9 million in funding, Aiforia and Nightingale Health got listed on the stock exchange. These are just a few examples of the great things currently happening in the Finnish health and life science sector.The effects of the current pandemic are comparable to other significant crises of humankind: the pandemic forces people to innovate together and invest in new solutions. Where World War II boosted nuclear physics and aircraft, the COVID-19 pandemic has turbo-boosted mRNA vaccine technology and caused a huge demand for e.g. digital health solutions.There’s a globally growing demand on the market, Finnish researchers have more and more courageous attitudes towards entrepreneurship and investors are interested in the health industry. These are all great news – but how can we boost innovation and make health an even better growth engine for Finland?
Three opportunities to boost health innovation in Finland
Improving legislation to enable the research use of Finland’s world-renowned health data
Increasing public RDI funding and ensure the continuation of strong RDI at HUS Helsinki University Hospital, and
Increasing startup funding: in addition to attracting international investors, domestic private equity funds with health focus are needed.
Health innovations can – not only create jobs and tax euros – actually save the mankind. Let’s all do our part to make Finland the best RDI environment for health and life sciences.Health Capital Helsinki
Presenting Health Incubator Helsinki batch 5 companies:
Estonian-based company EsaDres develops personalised wound dressings for the treatment of chronic wounds. The...
10 Dec 2024
Discover what our partners say about co-innovation with HCH.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
